Cardionerds: A Cardiology Podcast

475. Case Report: The Walls Have a Story: Rapidly Progressive AL Cardiac Amyloidosis – Georgetown/Washington Hospital Center

474. Cardiothoracic Surgery in Pulmonary Embolism with Dr. Joshua Goldberg

473. ACS Guidelines Question #11 with Dr. Venu Menon

Managing anemia in patients with Acute Coronary Syndrome (ACS) requires balancing clinical outcomes with resource stewardship, as highlighted by the 2025 ACS Guidelines. While restrictive transfusion strategies targeting hemoglobin levels of 7–8 g/dL are standard in general intensive care, the MINT trial suggests a pot...

471. ACS Guidelines Question #9 with Dr. Venu Menon

470. ACS Guidelines Question #8 with Dr. Venu Menon

Mechanical complications following acute myocardial infarction, such as ventricular septal rupture, necessitate urgent management at tertiary centers with specialized surgical expertise. While surgical repair remains the definitive treatment, current 2025 ACS guidelines emphasize the role of short-term mechanical circu...

469. ACS Guidelines Question #7 with Dr. Venu Menon

Managing cardiogenic shock in the setting of ST-elevation myocardial infarction (STEMI) requires careful selection of mechanical circulatory support (MCS) based on the 2025 ACS guidelines. For a 72-year-old patient with refractory shock and elevated filling pressures despite revascularization and vasopressors, the plac...

468. 2026 Acute Pulmonary Embolism Guidelines with Dr. Mark Creager

The 2026 multisocietal guidelines for pulmonary embolism (PE) introduce a refined five-tier classification system (A-E) to better define patient risk and guide clinical management. Dr. Mark Creager, chair of the writing committee, explains that this transition from older, less granular paradigms allows for more nuanced...

467. ACS Guidelines Question #6 with Dr. Binita Shah

Parenteral anticoagulation strategies for non-ST elevation acute coronary syndrome (NSTE-ACS) during percutaneous coronary intervention (PCI) must balance ischemic prevention against bleeding risks. Intravenous unfractionated heparin remains the standard of care with a Class 1 recommendation. While bivalirudin and enox...

466. ACS Guidelines Question #5 with Dr. Binita Shah

465. ACS Guidelines Question #4 with Dr. Binita Shah

Managing ST-elevation myocardial infarction (STEMI) in patients at non-PCI-capable centers requires precise adherence to the 2025 ACS Guidelines regarding fibrinolytic therapy and antithrombotic regimens. Clopidogrel remains the only P2Y12 inhibitor with a Class I recommendation for use alongside fibrinolytic agents, w...

464. ACS Guidelines Question #3 with Dr. Binita Shah

463. Multimodality Imaging in Chronic Coronary Artery Disease with Dr. Panithaya Chareonthaitawee

462. Tricuspid Regurgitation with Dr. Sunil Mankad

461. Pre-Pregnancy Risk Stratification and Counseling with Dr. Katy Young

460. Approach to HFpEF and the Metabolic Syndrome with Dr. John Ostrominski

459. The Continuum of Prevention and Heart Failure with Dr. Anu Lala and Dr. Martha Gulati

458. The Golden Age of Pulmonary Embolism Randomized Controlled Trials with Dr. Jay Giri

Pulmonary embolism management is undergoing a paradigm shift as the field transitions from observational data to a "golden age" of randomized controlled trials. While systemic thrombolysis effectively improves right ventricular function, its association with intracranial hemorrhage limits its routine use in intermediat...

457. Insights into INOCA and ANOCA with Dr. Claire Raphael

Non-obstructive coronary artery disease, including MINOCA, INOCA, and ANOCA, represents a significant clinical challenge where patients experience ischemia and chest pain despite "clean" angiograms. Interventional cardiologist Dr. Claire Raphael highlights that these conditions are frequently underdiagnosed, particular...

456. ACS Guidelines Question #2 with Dr. Michelle O’Donoghue

455. The Long-Term Management Of Patients With Pulmonary Embolism with Dr. Soophia Naydenov